Cook B L, Helms P M, Smith R E, Tsai M
J Affect Disord. 1986 Mar-Apr;10(2):91-4. doi: 10.1016/0165-0327(86)90031-5.
Nine of 15 elderly male VA outpatients receiving long-term tricyclic antidepressant therapy underwent gradual placebo substitution under double-blind conditions. Three of the 9 (33.3%) experienced a reoccurrence of depressive symptoms on placebo (at 4, 5 and 6 months). None of the 6 remaining on active medication experienced a reoccurrence. The Hamilton Depression Scale and Montgomery Asberg Depression Rating Scale scores indicate a significantly (P less than 0.05) worse outcome for those switched to placebo. The results suggest the need for close follow-up after discontinuation of antidepressant therapy in this population.
15名接受长期三环类抗抑郁药治疗的老年男性退伍军人门诊患者中,有9人在双盲条件下接受了逐步的安慰剂替代治疗。9名患者中有3名(33.3%)在服用安慰剂时(分别在4、5和6个月时)出现抑郁症状复发。继续服用活性药物的其余6名患者均未出现复发。汉密尔顿抑郁量表和蒙哥马利-阿斯伯格抑郁评定量表评分表明,改用安慰剂的患者预后明显更差(P<0.05)。结果表明,该人群停用抗抑郁药治疗后需要密切随访。